Pharmaceutical
Home » Ophthalmic Drugs Market

Ophthalmic Drugs Market

Ophthalmic Drugs Market By Prescription Type (Prescription Ophthalmic Drugs, OTC), By Therapeutics (Glaucoma, Retinal Disorder, Dry Eye, Allergic Conjunctivitis) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022
Report Book

Published Date: Aug 2016
Category: Pharmaceuticals
Report ID: 58033
Report Format: PDF
No of Pages: 190

Rating: Credence Reports

Market Insights:

The senior population is growing with the rising global population, and the rising patient base suffering from ocular and eye-related disorders has been a major growth driver that has urged the advent of the ophthalmic drugs market. In the next few years, the demand for ophthalmic drugs will increase significantly in emerging economies such as China and India.

The prescription types studied for analyzing the overall ophthalmic drug market are prescription drugs and over-the-counter (OTC) drugs. Based on therapeutic areas, the global ophthalmic drugs market is segmented into glaucoma, retinal disorders, ophthalmic drugs, dry eye, and allergic conjunctivitis. The market size and forecast for each of these segments for 2012–2022 are provided in this study, along with their respective CAGRs for the forecast period 2016–2022.

Geographically, the ophthalmic drug market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2014–2022. In addition, market growth rates for the forecast period 2016–2022 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global ophthalmic drugs market.

Tools such as market positioning of key players and attractive investment propositions provide the readers with insights into the competitive scenario of the global ophthalmic drugs market. This report concludes with a company profiles section highlighting major information about the key players in the ophthalmic drugs market.

Based on the type of prescription, the global ophthalmic drugs market is segmented as follows:

  • prescription ophthalmic drugs
  • Over-the-Counter (OTC) Drugs

The ophthalmic drug industry can be classified into prescription and over-the-counter (OTC) drugs. OTC drugs are widely adopted due to the large number of glaucoma patients and the increasing number of geriatric patients globally, creating a significant demand in the OTC drug market. However, various side effects associated with the uptake of OTC medications would hinder growth for the OTC market segment. 

The prescription ophthalmic drugs segment is anticipated to grow at the highest CAGR during the forecast period. The prime factor determining the growth of the prescription drugs segment is the increasing number of patients suffering from various new retinal disorders and complicated glaucoma and cataract cases. Moreover, an increasing success rate for newly launched drugs, which can only be purchased by prescription, would further assist the market’s growth. Ophthalmic steroids need a prescription to be given to the patient, as these products are specifically designed to be applied to the eyes. 

These products contain corticosteroids and are available as eye drops, gels, ointments, and other forms of ocular application. Some FDA-approved prescription ophthalmic drugs include Acular, Omidria, Betaxon, Zaditor, and Zymaxid.

Based on the type of therapeutic, the global ophthalmic drugs market is segmented as follows:

  • Glaucoma ophthalmic drugs
  • Retinal Disorder Ophthalmic Drugs
  • Dry Eye Ophthalmic Drugs
  • Allergic Conjunctivitis       

According to the World Health Organization (WHO), currently, more than 300 million people are affected by visual impairments and blindness, and this figure is expected to grow by 10% in the coming years (2020). About 90% of the worlds visually impaired reside in low-income groups. And 82% of people living with blindness are aged 50 and above. Worldwide, uncorrected refractive errors are the main cause of moderate and severe visual impairment and cataracts, which are the leading cause of blindness in the middle- and low-income countries.

On the basis of therapeutics, the global market for ophthalmic drugs is segmented into four categories: glaucoma ophthalmic drugs, retinal disorders ophthalmic drugs, dry eye ophthalmic drugs, and allergic conjunctivitis. Glaucoma ophthalmic drugs hold the largest share of the global ophthalmic drug market. It is estimated that over three million Americans are suffering from glaucoma, which is the leading cause of blindness in people over 60 years of age. Early detection and treatment with the help of glaucoma eye drops, glaucoma surgery, or both can help retain vision. Treatment can involve glaucoma surgery, lasers, or medication, depending on the severity. The retinal disorder ophthalmic drug is anticipated to grow at the highest CAGR due to a higher prevalence rate among people in the world. Thus, the treatment for retinal disorders has the highest growth rate. 

The geographical segmentation of the global ophthalmic drugs market comprises North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. In the base year of 2015, North America accounted for the largest market in the ophthalmic drugs market due to the rising number of patients suffering from ocular diseases in the region. The prevalence of blindness, vision impairment, and other eye-related disorders is expected to increase rapidly among all age groups, genders, and races in North America.

It has been estimated that age-related macular degeneration is expected to double by 2050, from 2.1 million to 3.7 million cases. However, factors such as high market saturation, drying pipelines, and increasing competition are some of the factors hampering the market potential of the North American ophthalmic drug market. Europe is the second-largest market for ophthalmic drugs. Better regulatory policies have led to increased trust in the drug market, which is the key factor driving the growth in the European market. The Asia Pacific ophthalmic drug market holds high growth potential in the near future due to factors such as the rising geriatric population, rising investments in healthcare infrastructure, and the increasing prevalence of ocular diseases, which include disorders of both the cornea and the retina.

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.2 List and Data Sources

Chapter 2 Executive Summary
2.1 Global Ophthalmic Drugs Market – Industry Summary & Key Buying Criteria
2.2 Global Ophthalmic Drugs Market – Industry Outlook

Chapter 3 Market Segmentation
3.1 Market Size and Growth Prospects 2012-2022
3.2 Global hthalmic Drugs Industry Value Chain Analysis
3.3 Vendor Landscape

Chapter 4 Global Ophthalmic Drugs Market Dynamics
4.1 Market Driver Analysis
4.1.1 Global Rise in Geriatric Population Pushing Ophthalmology Drugs
4.1.2 Technology Advancement
4.1.3 Innovation Giving Rise To Ophthalmology Drugs Market
4.1.4 Global Increase In Prevelance of Eye Diseases
4.1.5 Global Increase in Healthcare Expenditure
4.2 Market Driver Analysis
4.2.1 Major Drugs Going Off Patent Is Affecting the Growth of Ophthalmology Market
4.2.2 Drying Pipelines Is A Concern For Major Players
4.3 Key Opportunities Prioritized
4.2.1 Increasing Awareness
4.2.2 Emerging Markets

Chapter 5 Industry Analysis
6.1 Global Ophthalmic Drugs Market Industry – PESTEL Analysis

Chapter 6 Global Ophthalmic Drugs Market, By Prescription Type, 2012-2022 (USD Mn)
6.1 Global Prescription Market For Ophthalmic Drugs, 2012-2022 (USD Mn)
6.2 Global OTC (Over The Counter ) Drugs Ophthalmic Drugs Market 2012-2022 (USD Mn)

Chapter 7 Global Ophthalmic Drugs Market, By Therapeutic Type, 2012-2022 (USD Mn)
7.1 Global Glaucoma Ophthalmic Drugs, 2012-2022 (USD Mn)
7.2 Global Retinal Disorder Ophthalmic Drugs Market 2012-2022 (USD Mn)
7.3 Global Dry Eye Ophthalmic Drugs Market, 2012-2022 (USD Mn)
7.4 Global Allergic Conjunctivitis Ophthalmic Drugs Market 2012-2022 (USD Mn)

Chapter 8 Global Ophthalmology Drugs Market, By Geography
8.1 Overview
8.2 North America
8.2.1. U.S.
8.2.2. Canada
8.2.2. Mexico
8.3 Europe
8.2.1. U.K.
8.2.2. Germany
8.2.3. Russia
8.4 Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. South Korea
8.4 Middle East and Africa
8.5 Central & South America

Chapter 9 Company Profiles
9.1 Abbott Healthcare
9.1.1 Business Description
9.1.2 Financial Health and Budget Allocation
9.1.3 Product Portfolio
9.1.4 News Coverage
9.2 Allergan Plc
9.2.1 Business Description
9.2.2 Financial Health and Budget Allocation
9.2.3 Product Portfolio
9.2.4 News Coverage
9.3 Johnson & Johnson
9.3.1 Business Description
9.3.2 Financial Health and Budget Allocation
9.3.3 Product Portfolio
9.3.4 News Coverage
9.4 Bayer
9.4.1 Business Description
9.4.2 Financial Health and Budget Allocation
9.4.3 Product Portfolio
9.4.4 News Coverage
9.5 Valeant Pharmaceuticals, Inc.
9.5.1 Business Description
9.5.2 Financial Health and Budget Allocation
9.5.3 Product Portfolio
9.5.4 News Coverage
9.6 Akorn
9.6.1 Business Description
9.6.2 Financial Health and Budget Allocation
9.6.3 Product portfolio
9.6.4 News Coverage
9.7 Renegeron
9.7.1 Business Description
9.7.2 Financial Health and Budget Allocation
9.7.3 Product Portfolio
9.7.4 News Coverage
9.8 Eyemed
9.8.1 Business Description
9.8.2 Financial Health and Budget Allocation
9.8.3 Product Portfolio
9.8.4 News Coverage
9.9 Senju Pharmaceutical Co., Ltd
9.9.1 Business Description
9.9.2 Financial Health and Budget Allocation
9.9.3 Product Portfolio
9.9.4 News Coverage
9.10 Pfizer, Inc.
9.10.1 Business Description
9.10.2 Financial Health and Budget Allocation
9.10.3 Product Portfolio
9.10.4 News Coverage
9.11 Merck & Co.
9.11.1 Business Description
9.11.2 Financial Health and Budget Allocation
9.11.3 Product Portfolio
9.11.4 News Coverage
9.12 Novartis AG
9.12.1 Business Description
9.12.2 Financial Health and Budget Allocation
9.12.3 Product Portfolio
9.12.4 News Coverage
9.13 Glaxo Smith Kline
9.13.1 Business Description
9.13.2 Financial Health and Budget Allocation
9.13.3 Product Portfolio
9.13.4 News Coverage
9.14 Eyegate Pharmaceuticals
9.14.1 Business Description
9.14.2 Financial Health and Budget Allocation
9.14.3 Product Portfolio
9.14.4 News Coverage
9.15 LPath
9.15.1 Business Description
9.15.2 Financial Health and Budget Allocation
9.15.3 Product Portfolio
9.15.4 News Coverage
9.16 Senten Pharmaceutical Co. Ltd
9.15.1 Business Description
9.15.2 Financial Health and Budget Allocation
9.15.3 Product Portfolio
9.15.4 News Coverage
9.17 Cipla Pharmaceuticals
9.15.1 Business Description
9.15.2 Financial Health and Budget Allocation
9.15.3 Product Portfolio
9.15.4 News Coverage
9.18 Sun Pharmaceutical Industries, Ltd.
9.15.1 Business Description
9.15.2 Financial Health and Budget Allocation
9.15.3 Product Portfolio
9.15.4 News Coverage
9.19 Other Notable Players

Frequently Asked Questions:

What is the size of Ophthalmic Drugs Market?

The market for Ophthalmic Drugs Market is expected to reach USD 27.6 Bn By 2022.

What is the Ophthalmic Drugs Market CAGR?

The Ophthalmic Drugs Market is expected to see significant CAGR growth over the coming years, at 7.0%.

What is the Forecast period considered for Ophthalmic Drugs Market?

The report is forecasted from 2015 To 2022.

What is the base year considered for Ophthalmic Drugs Market?

The base year of this report is 2014.

Who are the major players in this market?

Abbott Healthcare, Allergan Plc, Johnson & Johnson, Bayer, Valeant Pharmaceuticals, Inc., are some of the major players in the global market.

Healthcare

Trientine Hydrochloride Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 58081
Report Format: PDF
No of Pages: 247

Pharmaceutical

Pharmaceutical Chemicals Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62118
Report Format: PDF
No of Pages: 247

Pharmaceutical

Wilson’s Disease Drugs Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 58947
Report Format: PDF
No of Pages: 190

Healthcare

Stretch Marks Treatment Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62116
Report Format: PDF
No of Pages: 221

Pharmaceutical

Fetal Bovine Serum Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62115
Report Format: PDF
No of Pages: 238

Healthcare

Cirrhosis Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62114
Report Format: PDF
No of Pages: 229

Pharmaceutical

Congenital Hyperinsulinism Treatment Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62113
Report Format: PDF
No of Pages: 219

Healthcare

Cryptococcal Meningitis Treatment Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62112
Report Format: PDF
No of Pages: 237

Healthcare

Dermatology Endoscopy devices Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62111
Report Format: PDF
No of Pages: 237

Healthcare

Cementless Total Knee Arthroplasty Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62110
Report Format: PDF
No of Pages: 228

Healthcare

Cell & Gene Therapy Clinical Trials Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62109
Report Format: PDF
No of Pages: 228

HealthCare

Self-sampling Blood Collection and Storage Device Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 61352
Report Format: PDF
No of Pages: 234

Download Sample Report


Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
WhatsApp Now